» Articles » PMID: 30139770

Quantitative High-resolution Computed Tomography Fibrosis Score: Performance Characteristics in Idiopathic Pulmonary Fibrosis

Overview
Journal Eur Respir J
Specialty Pulmonary Medicine
Date 2018 Aug 25
PMID 30139770
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

We evaluated performance characteristics and estimated the minimal clinically important difference (MCID) of data-driven texture analysis (DTA), a high-resolution computed tomography (HRCT)-derived measurement of lung fibrosis, in subjects with idiopathic pulmonary fibrosis (IPF).The study population included 141 subjects with IPF from two interventional clinical trials who had both baseline and nominal 54- or 60-week follow-up HRCT. DTA scores were computed and compared with forced vital capacity (FVC), diffusing capacity of the lung for carbon monoxide, distance covered during a 6-min walk test and St George's Respiratory Questionnaire scores to assess the method's reliability, validity and responsiveness. Anchor- and distribution-based methods were used to estimate its MCID.DTA had acceptable reliability in subjects appearing stable according to anchor variables at follow-up. Correlations between the DTA score and other clinical measurements at baseline were moderate to weak and in the hypothesised directions. Acceptable responsiveness was demonstrated by moderate to weak correlations (in the directions hypothesised) between changes in the DTA score and changes in other parameters. Using FVC as an anchor, MCID was estimated to be 3.4%.Quantification of lung fibrosis extent on HRCT using DTA is reliable, valid and responsive, and an increase of ∼3.4% represents a clinically important change.

Citing Articles

Integrating Radiomics Signature into Clinical Pathway for Patients with Progressive Pulmonary Fibrosis.

Sica G, DAgnano V, Bate S, Romano F, Viglione V, Franzese L Diagnostics (Basel). 2025; 15(3).

PMID: 39941208 PMC: 11817504. DOI: 10.3390/diagnostics15030278.


Evaluation of e-Lung automated quantitative computed tomography biomarkers in idiopathic pulmonary fibrosis.

George P, Rennison-Jones C, Benvenuti G, Sifostratoudaki A, Ottink F, Bou-Zeid W ERJ Open Res. 2024; 10(6).

PMID: 39624378 PMC: 11610042. DOI: 10.1183/23120541.00570-2024.


ESR Essentials: imaging in fibrotic lung diseases-practice recommendations by the European Society of Thoracic Imaging.

Larici A, Biederer J, Cicchetti G, Franquet Casas T, Screaton N, Remy-Jardin M Eur Radiol. 2024; .

PMID: 39242399 DOI: 10.1007/s00330-024-11054-2.


Quantitative parameters of HRCT target scan to predict the risk of lung adenocarcinoma based on the detection of lung ground-glass nodules.

Zhang J, Peng P Clin Transl Oncol. 2024; .

PMID: 39180703 DOI: 10.1007/s12094-024-03676-1.


Progressive Early Interstitial Lung Abnormalities in Persons at Risk for Familial Pulmonary Fibrosis: A Prospective Cohort Study.

Salisbury M, Markin C, Fadely T, Guttentag A, Humphries S, Lynch D Am J Respir Crit Care Med. 2024; 210(12):1441-1452.

PMID: 39137317 PMC: 11716039. DOI: 10.1164/rccm.202403-0524OC.